155 related articles for article (PubMed ID: 21843063)
1. A hub for bench-to-bedside pharmacogenomic-based research.
Voora D; Ginsburg GS
Pharmacogenomics; 2011 Aug; 12(8):1095-8. PubMed ID: 21843063
[TBL] [Abstract][Full Text] [Related]
2. Institutional profile: integrated center for research and treatment of vertigo, balance and ocular motor disorders.
Brandt T; Zwergal A; Jahn K; Strupp M
Restor Neurol Neurosci; 2010; 28(1):135-43. PubMed ID: 20086290
[TBL] [Abstract][Full Text] [Related]
3. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
4. Planning for a national effort to enable and accelerate discoveries in pharmacogenetics: the NIH Pharmacogenetics Research Network.
Long RM
Clin Pharmacol Ther; 2007 Mar; 81(3):450-4. PubMed ID: 17339874
[TBL] [Abstract][Full Text] [Related]
5. Ethics and policy perspectives on personalized medicine in the post-genomic era.
Landon MR
J Biolaw Bus; 2005; 8(3):28-36. PubMed ID: 16459425
[TBL] [Abstract][Full Text] [Related]
6. NIPTE: a multi-university partnership supporting academic drug development.
Gurvich VJ; Byrn SR
Drug Discov Today; 2013 Oct; 18(19-20):916-21. PubMed ID: 23732177
[TBL] [Abstract][Full Text] [Related]
7. Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research.
Kennedy MA; Joyce PR; Begg EJ
Pharmacogenomics; 2012 Jun; 13(8):865-8. PubMed ID: 22676191
[TBL] [Abstract][Full Text] [Related]
8. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
9. CAM evaluation comes into the mainstream: NIH specialized Centers of research and the University of Maryland Center for Alternative Medicine Research in Arthritis.
Berman BM; Hartnoll S; Bausell B
Complement Ther Med; 2000 Jun; 8(2):119-22. PubMed ID: 10859605
[TBL] [Abstract][Full Text] [Related]
10. NAVAGATE: a rubric to move from pharmacogenomics science to pharmacogenomics practice.
Roederer MW
Pharmacogenomics; 2012 Aug; 13(11):1307-13. PubMed ID: 22920399
[TBL] [Abstract][Full Text] [Related]
11. Institutional profile: the Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre at the Montreal Heart Institute.
Dubé MP; Tardif JC
Pharmacogenomics; 2013 Jan; 14(2):131-6. PubMed ID: 23327574
[No Abstract] [Full Text] [Related]
12. Pharmacogenomics and public health: implementing 'populationalized' medicine.
Mette L; Mitropoulos K; Vozikis A; Patrinos GP
Pharmacogenomics; 2012 May; 13(7):803-13. PubMed ID: 22594512
[TBL] [Abstract][Full Text] [Related]
13. Institutional profile: the Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
Alfirevic A; Carr DF; Miyajima F; Pushpakom S; Sutton L; Jorgensen AL; Pirmohamed M
Pharmacogenomics; 2013 Jun; 14(8):861-7. PubMed ID: 23746181
[TBL] [Abstract][Full Text] [Related]
14. Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.
Rakhra-Burris TK; Auman JT; Deverka P; Dressler LG; Evans JP; Goldberg RM; Havener TM; Hoskins JM; Jonas DE; Long KM; Motsinger-Reif AA; Irvin WJ; Richards KL; Roederer MW; Valgus JM; Riper Mv; Vernon JA; Zamboni WC; Wagner MJ; Walko CM; Weck KE; Wiltshire T; McLeod HL
Pharmacogenomics; 2010 Jan; 11(1):13-21. PubMed ID: 20017668
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic biomarkers for personalized medicine.
Chen JJ; Lin WJ; Chen HC
Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
[TBL] [Abstract][Full Text] [Related]
16. Company profile: PGXIS Ltd.
McCarthy A
Pharmacogenomics; 2011 Sep; 12(9):1253-6. PubMed ID: 21919604
[TBL] [Abstract][Full Text] [Related]
17. Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death".
Roberts SF; Fischhoff MA; Sakowski SA; Feldman EL
Acad Med; 2012 Mar; 87(3):266-70. PubMed ID: 22373616
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
Wei CY; Lee MT; Chen YT
Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
[TBL] [Abstract][Full Text] [Related]
19. Personalized medicine: progress and promise.
Chan IS; Ginsburg GS
Annu Rev Genomics Hum Genet; 2011; 12():217-44. PubMed ID: 21721939
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenomics: hype or hope?].
Schwab M; Schaeffeler E; Zanger UM; Brauch H; Kroemer HK
Dtsch Med Wochenschr; 2011 Mar; 136(10):461-7. PubMed ID: 21365522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
